ICD-10-CM changes for FY2027
ICD-10-CM adds 190 new codes and deletes 30 billable codes for fiscal year 2027: 15 were subdivided into more specific codes and 15 were retired outright. A further 4 descriptions changed. All changes take effect October 1, 2026 and apply to discharges and encounters through September 30, 2027. There is no grace period — the code set in force is determined by the date of service.
15 codes you can no longer bill
These codes still exist in ICD-10-CM but were subdivided for FY2027. Each became a non-billable header, so a claim carrying one will be rejected for lack of specificity. This is the change most likely to cause denials, because the code does not disappear from a lookup — it simply stops being valid to submit. Replace each with one of the child codes listed beneath it.
15 codes retired outright
These billable codes were removed from the classification and have no direct replacement. Any encounter on or after October 1, 2026 must be coded to a different, clinically appropriate code — check the Tabular List for the surrounding category before choosing one. A further 6 header codes were also removed; those were never billable, so they do not affect claims.
- S23.420ADeleted for FY2027
- S23.420DDeleted for FY2027
- S23.420SDeleted for FY2027
- T52.8X1ADeleted for FY2027
- T52.8X1DDeleted for FY2027
- T52.8X1SDeleted for FY2027
- T52.8X2ADeleted for FY2027
- T52.8X2DDeleted for FY2027
- T52.8X2SDeleted for FY2027
- T52.8X3ADeleted for FY2027
- T52.8X3DDeleted for FY2027
- T52.8X3SDeleted for FY2027
- T52.8X4ADeleted for FY2027
- T52.8X4DDeleted for FY2027
- T52.8X4SDeleted for FY2027
190 new codes
New billable codes available from October 1, 2026. Many exist because an older, broader code was subdivided — where that is the case, the parent is listed in the section above.
- C78.31Secondary malignant neoplasm of larynx
- C78.32Secondary malignant neoplasm of pharynx
- C79.83Secondary malignant neoplasm of oral cavity
- D69.11Glanzmann thrombasthenia
- D69.19Other qualitative platelet defects
- E89.830Post bariatric hypoglycemia
- E89.838Other postprocedural hypoglycemia
- F64.AGender identity disorder, in remission
- I42.00Dilated cardiomyopathy, unspecified
- I42.01Familial-genetic dilated cardiomyopathy
- I42.09Other dilated cardiomyopathy
- I42.81Arrhythmogenic cardiomyopathy
- I42.89Other cardiomyopathies not elsewhere classified
- I47.22Catecholaminergic polymorphic ventricular tachycardia [CPVT]
- I49.81Brugada syndrome
- I49.82Ventricular bigeminy
- I49.89Other specified cardiac arrhythmias not elsewhere classified
- J34.830Odontogenic sinusitis, maxillary sinus
- J34.831Odontogenic sinusitis, ethmoid sinus
- J34.832Odontogenic sinusitis, frontal sinus
- J34.833Odontogenic sinusitis, sphenoid sinus
- J34.839Odontogenic sinusitis, unspecified
- J4BPulmonary mycetoma
- K31.BHypertrophic pyloric stenosis, in childhood
- K6A.01Prevesical abscess
- K6A.09Other pelvic abscess
- K6A.8Other diseases of the pelvis, not elsewhere classified
- K74.0AHepatic fibrosis, moderate fibrosis
- K76.83Intestinal failure-associated liver disease
- L02.237Carbuncle of flank
- M04.3VEXAS syndrome
- M67.A01Plantar fasciitis, right foot
- M67.A02Plantar fasciitis, left foot
- M67.A09Plantar fasciitis, unspecified foot
- M72.20Plantar fascial fibromatosis, unspecified foot
- M72.21Plantar fascial fibromatosis, right foot
- M72.22Plantar fascial fibromatosis, left foot
- M86.8X11Other osteomyelitis, right shoulder
- M86.8X12Other osteomyelitis, left shoulder
- M86.8X19Other osteomyelitis, unspecified shoulder
- M86.8X21Other osteomyelitis, right upper arm
- M86.8X22Other osteomyelitis, left upper arm
- M86.8X29Other osteomyelitis, unspecified upper arm
- M86.8X31Other osteomyelitis, right forearm
- M86.8X32Other osteomyelitis, left forearm
- M86.8X39Other osteomyelitis, unspecified forearm
- M86.8X41Other osteomyelitis, right hand
- M86.8X42Other osteomyelitis, left hand
- M86.8X49Other osteomyelitis, unspecified hand
- M86.8X51Other osteomyelitis, right thigh
- M86.8X52Other osteomyelitis, left thigh
- M86.8X59Other osteomyelitis, unspecified thigh
- M86.8X61Other osteomyelitis, right lower leg
- M86.8X62Other osteomyelitis, left lower leg
- M86.8X69Other osteomyelitis, unspecified lower leg
- M86.8X71Other osteomyelitis, right ankle and foot
- M86.8X72Other osteomyelitis, left ankle and foot
- M86.8X79Other osteomyelitis, unspecified ankle and foot
- M86.8X80Other osteomyelitis, skull
- M86.8X81Other osteomyelitis, face and sinuses
- M86.8X89Other osteomyelitis, other site
- N99.860Intraoperative and postprocedural nipple ischemia
- N99.861Intraoperative and postprocedural nipple necrosis
- O00.121Right interstitial ectopic pregnancy without intrauterine pregnancy
- O00.122Left interstitial ectopic pregnancy without intrauterine pregnancy
- O00.129Unspecified interstitial ectopic pregnancy without intrauterine pregnancy
- O00.131Right interstitial ectopic pregnancy with intrauterine pregnancy
- O00.132Left interstitial ectopic pregnancy with intrauterine pregnancy
- O00.139Unspecified interstitial ectopic pregnancy with intrauterine pregnancy
- O00.31Cesarean scar ectopic pregnancy without intrauterine pregnancy
- O00.32Cesarean scar ectopic pregnancy with intrauterine pregnancy
- O00.41Cervical ectopic pregnancy without intrauterine pregnancy
- O00.42Cervical ectopic pregnancy with intrauterine pregnancy
- O00.511Right cornual ectopic pregnancy without intrauterine pregnancy
- O00.512Left cornual ectopic pregnancy without intrauterine pregnancy
- O00.519Unspecified cornual ectopic pregnancy without intrauterine pregnancy
- O00.521Right cornual ectopic pregnancy with intrauterine pregnancy
- O00.522Left cornual ectopic pregnancy with intrauterine pregnancy
- O00.529Unspecified cornual ectopic pregnancy with intrauterine pregnancy
- O31.40X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecified
- O31.40X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1
- O31.40X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2
- O31.40X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3
- O31.40X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4
- O31.40X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5
- O31.40X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetus
- O31.41X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecified
- O31.41X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1
- O31.41X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2
- O31.41X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3
- O31.41X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4
- O31.41X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5
- O31.41X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetus
- O31.42X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecified
- O31.42X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1
- O31.42X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2
- O31.42X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3
- O31.42X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4
- O31.42X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5
- O31.42X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetus
- O31.43X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecified
- O31.43X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1
- O31.43X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2
- O31.43X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3
- O31.43X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4
- O31.43X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5
- O31.43X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetus
- Q87.ALoeys-Dietz syndrome
- QA1.71Lynch syndrome
- QA1.790Familial cancer syndrome with pathogenic BRCA1 mutation
- QA1.791Familial cancer syndrome with pathogenic BRCA2 mutation
- QA1.792Li Fraumeni syndrome
- QA1.798Other inherited neoplasm predisposition syndrome of multiple systems
- R78.72Abnormal gadolinium level in blood
- T52.811AToxic effect of alkenes, accidental (unintentional), initial encounter
- T52.811DToxic effect of alkenes, accidental (unintentional), subsequent encounter
- T52.811SToxic effect of alkenes, accidental (unintentional), sequela
- T52.812AToxic effect of alkenes, intentional self-harm, initial encounter
- T52.812DToxic effect of alkenes, intentional self-harm, subsequent encounter
- T52.812SToxic effect of alkenes, intentional self-harm, sequela
- T52.813AToxic effect of alkenes, assault, initial encounter
- T52.813DToxic effect of alkenes, assault, subsequent encounter
- T52.813SToxic effect of alkenes, assault, sequela
- T52.814AToxic effect of alkenes, undetermined, initial encounter
- T52.814DToxic effect of alkenes, undetermined, subsequent encounter
- T52.814SToxic effect of alkenes, undetermined, sequela
- T52.821AToxic effect of cycloparaffins, accidental (unintentional), initial encounter
- T52.821DToxic effect of cycloparaffins, accidental (unintentional), subsequent encounter
- T52.821SToxic effect of cycloparaffins, accidental (unintentional), sequela
- T52.822AToxic effect of cycloparaffins, intentional self-harm, initial encounter
- T52.822DToxic effect of cycloparaffins, intentional self-harm, subsequent encounter
- T52.822SToxic effect of cycloparaffins, intentional self-harm, sequela
- T52.823AToxic effect of cycloparaffins, assault, initial encounter
- T52.823DToxic effect of cycloparaffins, assault, subsequent encounter
- T52.823SToxic effect of cycloparaffins, assault, sequela
- T52.824AToxic effect of cycloparaffins, undetermined, initial encounter
- T52.824DToxic effect of cycloparaffins, undetermined, subsequent encounter
- T52.824SToxic effect of cycloparaffins, undetermined, sequela
- T52.891AToxic effect of other organic solvents, accidental (unintentional), initial encounter
- T52.891DToxic effect of other organic solvents, accidental (unintentional), subsequent encounter
- T52.891SToxic effect of other organic solvents, accidental (unintentional), sequela
- T52.892AToxic effect of other organic solvents, intentional self-harm, initial encounter
- T52.892DToxic effect of other organic solvents, intentional self-harm, subsequent encounter
- T52.892SToxic effect of other organic solvents, intentional self-harm, sequela
- T52.893AToxic effect of other organic solvents, assault, initial encounter
- T52.893DToxic effect of other organic solvents, assault, subsequent encounter
- T52.893SToxic effect of other organic solvents, assault, sequela
- T52.894AToxic effect of other organic solvents, undetermined, initial encounter
- T52.894DToxic effect of other organic solvents, undetermined, subsequent encounter
- T52.894SToxic effect of other organic solvents, undetermined, sequela
- T59.821AToxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounter
- T59.821DToxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter
- T59.821SToxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela
- T59.822AToxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounter
- T59.822DToxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter
- T59.822SToxic effect of hexamethylene diisocyanate, intentional self-harm, sequela
- T59.823AToxic effect of hexamethylene diisocyanate, assault, initial encounter
- T59.823DToxic effect of hexamethylene diisocyanate, assault, subsequent encounter
- T59.823SToxic effect of hexamethylene diisocyanate, assault, sequela
- T59.824AToxic effect of hexamethylene diisocyanate, undetermined, initial encounter
- T59.824DToxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter
- T59.824SToxic effect of hexamethylene diisocyanate, undetermined, sequela
- T65.851AToxic effect of medetomidine, accidental (unintentional), initial encounter
- T65.851DToxic effect of medetomidine, accidental (unintentional), subsequent encounter
- T65.851SToxic effect of medetomidine, accidental (unintentional), sequela
- T65.852AToxic effect of medetomidine, intentional self-harm, initial encounter
- T65.852DToxic effect of medetomidine, intentional self-harm, subsequent encounter
- T65.852SToxic effect of medetomidine, intentional self-harm, sequela
- T65.853AToxic effect of medetomidine, assault, initial encounter
- T65.853DToxic effect of medetomidine, assault, subsequent encounter
- T65.853SToxic effect of medetomidine, assault, sequela
- T65.854AToxic effect of medetomidine, undetermined, initial encounter
- T65.854DToxic effect of medetomidine, undetermined, subsequent encounter
- T65.854SToxic effect of medetomidine, undetermined, sequela
- Z68.18Body mass index [BMI] 18.4 or less, adult
- Z68.19Body mass index [BMI] 18.5-19.9, adult
- Z77.013Contact with and (suspected) exposure to gadolinium
- Z77.32Contact with and (suspected) exposure to burn pits in war theater
- Z77.33Contact with and (suspected) exposure to Agent Orange
- Z77.40Contact with and (suspected) exposure to unspecified blast overpressure
- Z77.41Contact with and (suspected) exposure to low-level blast overpressure
- Z77.42Contact with and (suspected) exposure to high-level blast overpressure
- Z77.49Contact with and (suspected) exposure to other blast overpressure
- Z86.17Personal history of Clostridioides difficile infection
- Z87.8901Personal history of social gender transition
- Z87.8902Personal history of medical gender transition
- Z87.8903Personal history of surgical gender transition
- Z87.8904Personal history of intersex surgery
- Z87.8909Personal history of unspecified gender transition
- Z87.893Personal history of gender detransition
4 revised descriptions
These codes keep their identifier but their official description changed. The code remains valid to submit; the wording in your encoder or superbill may now be out of date.
Derived from the official FY2027 addenda published by the CDC/NCHS, and reconciled against its summary block: 190 additions, 30 code deletions (15 subdivided, 15 retired), 6 header deletions, 4 revisions. The split between “subdivided” and “retired” is derived here — the official file lists both simply as deletions. See data sources.